XML 43 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity Instruments (Details Textual) (USD $)
3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2012
Warrants
Jun. 30, 2012
Common Stock [Member]
Jun. 30, 2012
Stock Option [Member]
Jun. 30, 2012
Series C Convertible Preferred Stock [Member]
Jun. 30, 2012
Warrant [Member]
Jun. 30, 2012
Warrant [Member]
Jun. 30, 2012
Series D Convertible Preferred Stock [Member]
Jan. 04, 2012
Series D Convertible Preferred Stock [Member]
Jun. 30, 2012
Stock Incentive Compensation Plans [Member]
Jun. 30, 2012
Stock Incentive Compensation Plans [Member]
Maximum [Member]
Jun. 30, 2012
Non Qualified Directors Plan [Member]
Jun. 30, 2012
Non Qualified Directors Plan [Member]
Initial [Member]
Equity Instruments [Line Items]                          
Conversion rate of preferred stock into common stock     316.28                    
Convertible preferred stock, shares issued upon conversion               100,000          
Number of common stock each holder owns               500,000          
Common stock, shares authorized                     5,200,000    
Options available for grant                   43,938,100   796,668  
Share-based compensation arrangement by share-based payment award, options, outstanding, ending balance                   7,030,900   105,000  
Options exercisable                   6,413,000   65,000  
Non qualified stock options to our non employee directors                       1,000,000  
Initial options granted                         25,000
Options granted annually                       15,000  
Liquidation preference per share value         $ 250                
Liquidation preference value         $ 2,600,000                
Series D convertible preferred stock, vested shares               7,000          
Preferred stock, shares issued                 250        
Preferred stock ,vesting period               10 years          
Number of warrants cancelled in exchange of share issue   120                      
Compensation Costs, Unrecognized       112,000   204,000 204,000 3,600,000          
Compensation Costs ,Expected Weighted-Average period       13 months     37 months 9 years 6 months          
Options vested fair value gross 11,148 11,148       5,708 5,708            
Warrants to purchase               100          
Equity instrument (Textual) [Abstract]                          
Compensation Costs Related to Warrants, Derecognized 32,000 24,000                      
Compensation costs recognized 73,000 168,000                      
Compensation Costs, Unrecognized       112,000   204,000 204,000 3,600,000          
Compensation Costs ,Expected Weighted-Average period       13 months     37 months 9 years 6 months          
Dividend Issued Treated as Conversion Percent 50.00% 50.00%                      
Options Outstanding and Exercisable 1,500,000 1,500,000                      
Tax benefits attributable to stock based compensation expense recognized $ 15,000 $ 34,000